Cargando…
LncRNA BCAR4, targeting to miR-665/STAT3 signaling, maintains cancer stem cells stemness and promotes tumorigenicity in colorectal cancer
BACKGROUND: Breast cancer anti-estrogen resistance 4 (BCAR4) is closely associated with colorectal cancer (CRC) initiation and propagation. However, the mechanisms underlying BCAR4 function in colon cancer remains largely unknown. In this study, we hypothesized that BCAR4 could regulate colon cancer...
Autores principales: | Ouyang, Shurui, Zhou, Xin, Chen, Zhengquan, Wang, Maijian, Zheng, Xinbin, Xie, Ming |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6438025/ https://www.ncbi.nlm.nih.gov/pubmed/30962766 http://dx.doi.org/10.1186/s12935-019-0784-3 |
Ejemplares similares
-
LncRNA BCAR4 promotes colon cancer progression via activating Wnt/β-catenin signaling
por: Ouyang, Shurui, et al.
Publicado: (2017) -
BMX-ARHGAP fusion protein maintains the tumorigenicity of gastric cancer stem cells by activating the JAK/STAT3 signaling pathway
por: Xu, Xiao-Feng, et al.
Publicado: (2019) -
LncRNA XIST/miR-200c regulates the stemness properties and tumourigenicity of human bladder cancer stem cell-like cells
por: Xu, Ran, et al.
Publicado: (2018) -
The Value of LncRNA BCAR4 as a Prognostic Biomarker on Clinical Outcomes in Human Cancers
por: Tu, Chao, et al.
Publicado: (2019) -
LncRNA MONC suppresses the malignant phenotype of Endometrial Cancer Stem Cells and Endometrial Carcinoma Cells by regulating the MiR-636/GLCE axis
por: Li, Yibing, et al.
Publicado: (2021)